NEOG - Neogen Corp.
5.93
0.440 7.420%
Share volume: 6,059,618
Last Updated: 05-07-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$5.49
0.44
0.08%
View ratios
| Fiscal Date | 02-28-2023 | 05-31-2023 | 11-30-2023 | 02-29-2024 | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2023 | Q4 2023 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q2 2025 | Q3 2025 | |
| Report Date | 04-04-2023 | 08-15-2023 | 01-09-2024 | 04-09-2024 | 01-15-2025 | 10-10-2024 | 01-15-2025 | 04-09-2025 | |
| Total revenue | 218.255 M | 241.810 M | 229.629 M | 228.812 M | 236.794 M | 216.964 M | 231.258 M | 220.980 M | |
| Cost of revenue | 110.291 M | 118.628 M | 112.855 M | 111.929 M | 123.312 M | 112.038 M | 117.928 M | 110.715 M | |
| Gross profit | 107.964 M | 123.182 M | 116.774 M | 116.883 M | 113.482 M | 104.926 M | 113.330 M | 110.265 M | |
| 14.10% | -5.20% | 0.09% | -2.91% | -7.54% | 8.01% | -2.70% | |||
| Operating expenses | 92.280 M | 99.757 M | 57.477 M | 56.940 M | 56.105 M | 56.870 M | 62.879 M | 60.255 M | |
| Selling general and admin | 85.022 M | 92.703 M | 51.721 M | 52.087 M | 50.960 M | 51.671 M | 57.771 M | 55.782 M | |
| Research and development | 7.258 M | 7.054 M | 5.756 M | 4.853 M | 5.145 M | 5.199 M | 5.108 M | 4.473 M | |
| Total expenses | 202.571 M | 218.385 M | 102.309 M | 104.860 M | 100.442 M | 102.669 M | 570.814 M | 104.850 M | |
| 7.81% | -53.15% | 2.49% | -4.21% | 2.22% | 455.98% | -81.63% | |||
| Operating income | 15.684 M | 23.425 M | 14.465 M | 12.023 M | 13.040 M | 2.257 M | -457.484 M | 5.415 M | |
| Ebit | 15.684 M | 23.425 M | 12.422 M | 10.851 M | 11.125 M | 0.000 | -459.205 M | 7.311 M | |
| Pretax income | -2.260 M | 7.650 M | -3.747 M | -5.822 M | -6.399 M | -15.609 M | -476.572 M | -9.727 M | |
| -438.50% | -148.98% | 55.38% | 9.91% | 143.93% | 2,953.19% | -97.96% | |||
| Income tax | -10.450 M | 2.078 M | -260.000 K | -3.800 M | -984.000 K | -3.000 M | -20.290 M | 1.230 M | |
| Net income basic | 8.190 M | 5.572 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -31.97% | -100.00% | ||||||||
| Net income | 8.190 M | 5.572 M | -3.487 M | -2.022 M | -5.415 M | -12.609 M | -456.282 M | -10.957 M | |
| -31.97% | -162.58% | 42.01% | -167.80% | -132.85% | -3,518.70% | 97.60% |
